Objectives of the Bulk Drug Park Scheme
- To promote the creation of bulk drug parks around the country so that the bulk drug units located within the park can conveniently use first-rate Common Infrastructure Facilities (CIF). By making the local bulk drug business more competitive, the production cost of bulk medications will be drastically reduced, enabling India to become self-sufficient in bulk drugs.
- To assist industry in lowering the cost of meeting environmental criteria through creative approaches to the current waste management system.
- To reap the rewards brought about by resource optimization and economies of scale.
- Despite being the third-largest pharmaceutical sector in the world (by volume), India heavily depends on the importation of bulk medications or APIs. According to information provided by the Ministry of Chemicals and Fertilizers, 63% of all pharmaceutical imports into the nation in 2018–19 were bulk medicine imports.
- Indian pharmaceutical businesses encountered difficulties as a result of the new coronavirus outbreak and subsequent lock-downs because API imports were affected.
- The Bulk Drug Park Promotion Scheme has a total budget of Rs. 3000 crore and a five-year duration (2020-21 to 2024-25). With a cap of Rs. 1000 crore per park or 70% of the project cost of Common Infrastructure Facilities, whichever is smaller, the initiative will offer grant-in-aid to three Bulk Drug Parks. The grant-in-aid for hilly states and the North East region is set at Rs. 1000 crore per park or, if less, 90% of the project cost for common infrastructure facilities.
Bulk Drug Park Scheme
The essential component of a drug or treatment that gives it the desired therapeutic effect or causes it to exhibit the specified pharmacological activity is known as a bulk drug, also known as an active pharmaceutical ingredient (API). When combined with binders to create finished pharmaceutical goods like Paracetamol tablets and capsules, it works as an analgesic. The area known as Bulk Drug Park has shared infrastructure resources for the sole purpose of manufacturing APIs, DIs, or KSM. There will be a shared waste management system at Bulk Drug Park. The Government of India approved the “Promotion of Bulk Drug Parks” Scheme on March 20, 2020, with the goal of significantly reducing the cost of manufacturing bulk drugs and thereby increasing the competitiveness of the domestic bulk drug industry by facilitating easy access to standard testing & infrastructure facilities.
13 states submitted plans for the building of bulk drug parks as part of this plan. Gujarat, Himachal Pradesh, and Andhra Pradesh have been chosen among them. According to a central government plan to establish three such parks around the nation that was revealed earlier this year, Himachal Pradesh is one of the states competing for the allocation of a bulk drug park. Himachal provides water and electricity at the nation’s lowest rates, and the state also has an industrial gas pipeline. It climbed nine spots in this year’s rankings for business-friendliness, which were released by the Center last month, to claim seventh place nationwide.